Effects of liraglutide and empagliflozin added to insulin therapy in patients with type 2 diabetes:...
Effects of liraglutide and empagliflozin added to insulin therapy in patients with type 2 diabetes: A randomized controlled study
About this item
Full title
Author / Creator
Publisher
Japan: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Japan: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Aims/Introduction
Liraglutide and empagliflozin suppress cardiovascular events. However, reports on their long‐term combined use with insulin therapy or direct comparisons of these drugs are limited.
Materials and Methods
This open‐label, parallel‐group, randomized controlled trial compared the effects of liraglutide and empagliflozin comb...
Alternative Titles
Full title
Effects of liraglutide and empagliflozin added to insulin therapy in patients with type 2 diabetes: A randomized controlled study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c810c0ec5cb94520ae3dff807730d3cb
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c810c0ec5cb94520ae3dff807730d3cb
Other Identifiers
ISSN
2040-1116
E-ISSN
2040-1124
DOI
10.1111/jdi.13270
